Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Hematology & Oncology|December 10, 2021
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicityZhaoming Wang, Chaobo Yin, Lawrence G Lum, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
Quantifying PD1 saturation by PDL1 in tumor tissue using a novel RNA aptamer-based assaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.International Journal of Molecular Sciences|June 26, 2026
Quantifying PD1 Saturation by PDL1 in Tumor Tissue Using a Novel RNA Aptamer-Based AssaySuresh Veeramani, Chaobo Yin, Nanmeng Yu, et al.Human Molecular Genetics|February 8, 2006
Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilinHongmin Wang, Precious J Lim, Chaobo Yin, et al.Frontiers in Immunology|March 4, 2026
BDCA2 plays a central role in the binding, internalization and response of plasmacytoid dendritic cells to vidutolimodCaitlin D Lemke-Miltner, Sue E Blackwell, Chaobo Yin, et al.Journal of Cell Science|September 14, 2006
Characterization of erasin (UBXD2): a new ER protein that promotes ER-associated protein degradationJing Liang, Chaobo Yin, Howard Doong, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2012
Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivoXiaocai Yan, Kara Doffek, Chaobo Yin, et al.Blood|March 8, 2024
T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCCJyoti Arora, Sabarish Ayyappan, Chaobo Yin, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2020
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ ImmunizationCaitlin D Lemke-Miltner, Sue E Blackwell, Chaobo Yin, et al.Vaccines|September 28, 2021
Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to VidutolimodShakoora A Sabree, Caitlin D Lemke-Miltner, Sue E Blackwell, et al.Pageof 1